Bio-Rad, FDA, Chicago Community Trust, Applied Biosystems, Stanford, University of Miami, Becton Dickinson, Clontech | GenomeWeb

Bio-Rad Gets FDA Nod for Automated Immunoassay Platform and Rapid HIV Antibody Detection Assay

Bio-Rad Laboratories received two FDA clearances in early January, getting agency approval to market its BioPlex 2200 automated immunoassay platform, and a rapid test to detect HIV antibodies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.